Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with ...

Switching to extended half-life therapies for hemophilia enhances treatment adherence and reduces infusion frequency, despite ...

Driven by expensive drugs, hospital stays and growing behavioral health needs, healthcare spending is expected to keep rising ...

H. pylori infection significantly contributes to stomach cancer risk, but effective screening and treatment can prevent ...

A panelist discusses how the FDA approval and NCCN endorsement of retifanlimab plus carboplatin/paclitaxel represents a ...

An expert discusses how patients with vitiligo are often initially misdiagnosed by primary care providers as having fungal ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

Elevidys is a gene therapy approved to treat Duchenne muscular dystrophy. Last month, Sarapta halted sales of the therapy for non-ambulatory patients.

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

Mulugeta Gebregziabher, Ph.D., spoke with Managed Healthcare Executive ahead of his presentation at IAS 2025 in Kigali, ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...